We relentlessly pursue every possibility to create new cancer breakthroughs and power our approach with people who think hard, care hard, and act with urgency. %
Location: United States, Connecticut, Stamford
Employees: 51-200
Total raised: $453M
Founded date: 2017
Investors 5
| Date | Name | Website |
| - | Bain Capit... | baincapita... |
| - | OrbiMed | orbimed.co... |
| - | Perceptive... | perceptive... |
| - | HBM Partne... | hbmpartner... |
| - | Bain Capit... | baincapita... |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 12.09.2022 | - | $225M | - |
| 02.04.2019 | Series B | $125M | - |
| 25.09.2017 | Series A | $103M | - |
Mentions in press and media 23
| Date | Title | Description | Source |
| 16.11.2023 | How do we know Alzheimer’s drugs ‘work’? | Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech ne... | statnews.c... |
| 07.09.2022 | GSK helps SpringWorks to double payday from boosted combo de... | It’s a good day to be the CFO of SpringWorks Therapeutics. The precision medicine biotech has not on... | fiercebiot... |
| 07.09.2022 | SpringWorks Therapeutics Announces $225 Million Private Plac... | - | orbimed.co... |
| 13.12.2021 | Don’t let ‘shelved assets’ gather dust. Make them into new l... | Life-science companies have changed the world with the breakthrough vaccines and therapeutics they c... | statnews.c... |
| 23.11.2021 | SpringWorks Therapeutics to Participate in the 4th Annual Ev... | STAMFORD, Conn., Nov. 23, 2021 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a ... | marketscre... |
| 11.11.2021 | SpringWorks Therapeutics Corporate Presentation | Corporate Presentation November 2021 NASDAQ: SWTX Forward-Looking Statements Note: Unless otherwise ... | marketscre... |
| 02.04.2019 | SpringWorks Therapeutics Inks $125M Series B | STAMFORD, CT, SpringWorks Therapeutics announced the closing of a $125 million Series B preferred ... | vcnewsdail... |
| 02.04.2019 | SpringWorks Therapeutics nabs $125M Series B | SpringWorks Therapeutics, a developer of medicines for patients with cancer and rare diseases, has r... | pitchbook.... |
| 01.04.2019 | SpringWorks Therapeutics Completes $125 Million Series B Fin... | STAMFORD, Conn.--(BUSINESS WIRE)--SpringWorks Therapeutics, Inc., a clinical-stage biopharmaceutical... | citybizlis... |
| 01.04.2019 | Daily funding roundup - April 1st, 2019 | Novo raised $4.8M; BillionToOne landed $15M; Academia.edu secured $16M; CollegeVine raised $24 Novo:... | vator.tv/n... |
Show more